Novavax Inc (NVAX)

R&D Expense Growth

-25.95%

Quarterly · Period ending:

NVAX logo

NVAX R&D Expense Growth

Latest reported-25.95%
NVAX Quarterly R&D Growth (QoQ) (0.00% → -25.95%)
High-resolution chart · PNG

NVAX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
48.0324%
-7.3293%
-4.3434%
38.3814%
38.6483%
27%
9.0909%
83.3333%
20%
-61.5385%
44.4444%
28.5714%
16.6667%
-33.3333%
28.5714%
-12.5%
33.3333%
-50%
50%
-11.1111%
12.5%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.